Acute Pancreatitis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| CalciMedica, Regeneron Pharmaceuticals and Others.
Acute pancreatitis is characterized by inflammation of the exocrine pancreas which occurs as a result of auto digestion of the pancreas by pancreatic enzymes. AP is associated with acinar cell injury and both a local and systemic inflammatory response. The incidence of acute pancreatitis has been increasing worldwide, but the major etiologies remain gallstones and alcohol.
DelveInsight's "Acute
Pancreatitis Market Insights, Epidemiology, and Market
Forecast-2030" report delivers an in-depth understanding of the
Acute Pancreatitis, historical and forecasted epidemiology as well as the Acute
Pancreatitis market trends in the United States, EU5 (Germany, Spain, Italy,
France, and United Kingdom) and Japan.
Some Key Highlights from the Acute
Pancreatitis Market Report:
·
The United States
accounted for the largest market size of AP i.e. USD 498.37 Million in 2020
·
According to
Delveinsight’s estimates, total diagnosed incident population of AP in the 7MM
was 502,390 in 2020.
·
The estimates
suggest that the gender based incidence varied in the 7MM with the male
incident cases higher in the United Kingdom, Japan, and Germany, whereas in the
United States the female incident cases were higher.
·
In approximately
15% of cases, patient can develop severe pancreatitis with tissue damage (also
called Acute Necrotizing Pancreatitis (ANP)).
·
As per a study by
Vege et al., the reported annual incidence of acute pancreatitis in the United
States ranges from 4.9 to 35 per 100,000 population.
·
According to a
study published by Ouyang et al., 2017, the incidence of acute pancreatitis
ranges from 13 to 45 per 100,000 population-years and that of chronic
pancreatitis ranges from 5 to 12 per 100,000 population-years.
View Report: https://www.delveinsight.com/report-store/acute-pancreatitis-market
To gain more insights request sample @ https://www.delveinsight.com/sample-request/acute-pancreatitis-market
According
to The National Pancreas Foundation, acute pancreatitis is an inflammatory
condition of the pancreas that is painful and deadly. Despite the great
advances in critical care medicine over the past 20 years, acute pancreatitis’
mortality rate has remained at about 10%. Diagnosis of pancreatic problems is
often difficult, and treatments are delayed because the organ is relatively
inaccessible.
There
are no easy ways to see the pancreas directly without surgery, and available
imaging studies are often inadequate. In addition to the acute form, there are
hereditary and chronic forms of pancreatitis that can devastate a person over
many years. Sufferers often endure pain and malnutrition and are most likely
left with a higher risk of pancreatic cancer.
View Report: https://www.delveinsight.com/report-store/acute-pancreatitis-market
To gain more insights request sample @ https://www.delveinsight.com/sample-request/acute-pancreatitis-market
Some of the Acute
Pancreatitis Companies:
·
CalciMedica, Inc
·
St. Jude
Children's Research Hospital
·
Regeneron
Pharmaceuticals
·
SCM Lifescience
Co., LTD
·
And Many Others
Acute
Pancreatitis Pipeline Therapies:
- CM-4620-IE
- Evinacumab
- SCM-AGH
- And Many Others
View Report: https://www.delveinsight.com/report-store/acute-pancreatitis-market
Request for Sample Report @ https://www.delveinsight.com/sample-request/acute-pancreatitis-market
Table of Contents
1. |
Report Introduction |
2. |
Executive Summary of Acute
Pancreatitis |
3. |
Acute Pancreatitis Market Overview
at a Glance |
4. |
Disease Background and Overview:
Acute Pancreatitis |
5. |
Case Reports of Acute Pancreatitis |
6. |
Acute Pancreatitis Patient Journey |
7. |
Acute Pancreatitis Epidemiology and
Patient Population |
8. |
Epidemiology of Acute Pancreatitis
by Countries (2018–2030) |
9. |
Acute Pancreatitis Treatments and
Medical Practices |
10. |
Acute Pancreatitis Marketed
Therapies |
11. |
Acute Pancreatitis Emerging
Therapies |
12. |
Acute Pancreatitis Market Size |
13. |
7MM: Country-wise Market Analysis |
14. |
Acute Pancreatitis Market Drivers |
15. |
Acute Pancreatitis Market Barriers |
16. |
SWOT Analysis |
17. |
KOL Views |
18. |
Reimbursement and market access |
19. |
Report Methodology |
20. |
DelveInsight Capabilities |
21. |
Disclaimer |
22. |
About DelveInsight |
About DelveInsight
DelveInsight is a leading Business
Consultant and Market Research firm focused exclusively on life sciences. It
supports Pharma companies by providing end to end comprehensive solutions to
improve their performance.
Acute Pancreatitis market,Acute
Pancreatitis market trends,Acute Pancreatitis market forecast,Acute
Pancreatitis market share,Acute Pancreatitis pipeline,Acute Pancreatitis
treatment algorithm,Acute Pancreatitis drugs,Acute Pancreatitis market
size,Acute Pancreatitis CAGR,Acute Pancreatitis epidemiology
Comments
Post a Comment